RNAC Stock Analysis: Buy, Sell, or Hold?
RNAC - Cartesian Therapeutics, Inc. Common Stock
$8.62
-0.01 (-0.12%)
▼
5d:
-14.23%
30d:
+6.95%
90d:
+45.36%
WAIT
LOW Confidence
Analysis Updated: Jul 14, 2026 12:00 AM ET
Earnings: Aug 06, 2026
21d
Get Alerted When RNAC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: RNAC is down 14.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: RNAC is down 14.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: RNAC is currently trading at $8.62, which is considered fair relative to its 30-day fair value range of $7.81 to $10.40.
Technical Outlook: Technically, RNAC is showing sideways momentum. Immediate support is located at $5.77, while resistance sits at $9.33.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $34.57 (+301.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, RNAC is showing sideways momentum. Immediate support is located at $5.77, while resistance sits at $9.33.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $34.57 (+301.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$7.81 -
$10.40
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.7%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 301.1% below Wall St target ($34.57)
- WARNING: Recommendation downgraded due to -14.2% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$7.81 -
$10.40
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$5.77
Resistance Level
$9.33
Current Trend
Sideways
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.22
Wall Street Target
$34.57
(+301.1%)
Revenue Growth (YoY)
-92.9%
Earnings Growth (YoY)
-7.4%
Share & Embed Analysis
Last updated: July 14, 2026 10:11 PM ET
Data refreshes hourly during market hours. Next update: 11:11 PM
Data refreshes hourly during market hours. Next update: 11:11 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RNAC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 58 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$555 | 51 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 55 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$108 | 57 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$28 | 62 BUY |
